News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Music

CHART TOPPERS: This week’s top alt tracks

tompetty

LISTEN: This week's top alternative tracks, according to the latest Billboard charts.

in Trending, Viral Videos

TODAY’S MUST SEE: Johnny JamBoogie

18-overlay8

If football doesn't workout, "Johnny Football" always has this to fall back on.

in Viral Videos

Boy’s hilarious reaction to baby news

19-overlay3

This little boy is NOT excited about being a big brother again, but his reaction is priceless.

in Viral Videos

Dad catches daughter taking selfies

11-overlay8

This teenage girl takes more photos of herself in this 58-second video, than you have all year.

in Music

Michael Jackson’s hometown plans three-day birthday bash

FILE - In this March 5, 2009 file photo, Michael Jackson is shown at a press conference in London. Testimony from AEG Live executive Paul Gongaware on his interactions with Jackson and his negotiations with the singer’s doctor dominated the fifth week of a civil case against the company filed by the superstar’s mother, Katherine. On Tuesday May 28, 2013, Gongaware reluctantly acknowledged that he negotiated the $150,000 per month rate that Jackson’s doctor expected to be paid to serve on the “This Is It” tour.

The King of Pop's boyhood home of Gary, Indiana will celebrate this weekend with the Michael Jackson Tribute Festival of the Arts.